GO:0035692 macrophage migration inhibitory factor receptor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035692 describes the macrophage migration inhibitory factor receptor complex, a cell surface protein complex that binds MIF and comprises CD74 and CD44 [1, 4, 8].
• CD74 is the ligand-binding subunit, while CD44 serves as a signal-transducing co-receptor; additional chemokine receptors such as CXCR4 can participate in heteromeric MIF receptor complexes [4, 8].
• MIF binding to this receptor complex triggers downstream signaling that regulates immune cell activation, survival, and cytokine production [1, 2, 3].
• Dysregulation of the MIF receptor complex is implicated in inflammatory diseases, COVID-19 immunopathology, glioblastoma, and metabolic liver disease [1, 5, 7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of CD74 and CD44 contributions to MIF signaling [1, 4, 8].
• Studying this complex requires integrated methods including flow cytometry, co-immunoprecipitation, RNA-seq, and functional immune assays [1, 2, 8].
Description
The macrophage migration inhibitory factor receptor complex (GO:0035692) is a cell surface protein complex that binds macrophage migration inhibitory factor (MIF) and is defined by the presence of CD74 and CD44 [1, 4]. MIF is a pleiotropic cytokine originally identified for its ability to inhibit macrophage migration, and its biological effects depend on engagement of this receptor complex. The complex is a cellular component that bridges extracellular MIF signals to intracellular signaling cascades, making it a focal point for understanding inflammatory and immune-mediated diseases [2, 3]. Researchers study GO:0035692 because it represents the molecular interface through which MIF exerts its pro-inflammatory, pro-survival, and proliferative effects across diverse cell types [3, 5, 6]. The receptor complex is not a static entity; its composition can vary, with CD74 forming functional heteromeric complexes with CD44 or chemokine receptors such as CXCR4 to mediate distinct signaling outcomes [4, 8]. This heterogeneity has important implications for how MIF signals in different tissues and disease contexts [1, 7]. Understanding the assembly, regulation, and downstream consequences of the MIF receptor complex is essential for developing targeted therapies against MIF-driven pathologies [3, 7].
macrophage migration inhibitory factor receptor complex At A Glance
| GO ID | GO:0035692 |
|---|---|
| GO term | macrophage migration inhibitory factor receptor complex |
| Ontology | cellular_component |
| Synonym | None listed |
| Definition | A protein complex that binds macrophage migration inhibitory factor. Comprises CD74 and CD44 cell surface proteins. |
| Major function | Binds MIF and initiates downstream signaling involved in immune regulation, cell survival, and proliferation [1, 2, 3]. |
| Key subunits | CD74 (ligand-binding) and CD44 (signal-transducing co-receptor); CXCR4 can form heteromeric complexes with CD74 [4, 8]. |
| Cellular location | Cell surface / plasma membrane [1, 4]. |
| Related diseases | COVID-19 immunopathology, inflammatory arthritis, glioblastoma, non-alcoholic steatohepatitis [1, 2, 5, 7]. |
What Is GO:0035692?
According to the Gene Ontology, GO:0035692 (macrophage migration inhibitory factor receptor complex) is a protein complex that binds macrophage migration inhibitory factor. It comprises the CD74 and CD44 cell surface proteins. This definition places the complex in the cellular component ontology, indicating it is a physical structure located at the cell surface that mediates ligand recognition and signal initiation [1, 4].
Why Is macrophage migration inhibitory factor receptor complex Important in Cell Biology?
The MIF receptor complex is important because it serves as the primary gateway for MIF-mediated signaling, which controls fundamental processes such as immune cell activation, survival, and cytokine production [2, 3]. Dysregulation of this complex contributes to a wide range of human diseases, including severe COVID-19, autoimmune arthritis, glioblastoma, and metabolic liver disease [1, 2, 5, 7]. Because CD74 and CD44 are the defining components, they represent tractable targets for therapeutic intervention and for CRISPR-based functional studies [1, 4, 8].
• Mediates MIF-dependent activation of the NLRP3 inflammasome in immune complex-driven inflammation.
• Regulates effector T cell expansion and differentiation, with CD74 expression associated with COVID-19 severity.
• Supports cell survival and proliferation in neural stem/progenitor cells and glioblastoma [5, 6].
• Promotes pro-fibrotic responses in non-alcoholic steatohepatitis through shifts in NKT cell populations.
• Forms functional heteromeric receptor complexes with CXCR4, expanding the repertoire of MIF signaling.
• CD74 acts as an invariant chain with chaperone functions beyond antigen presentation.
• Provides a molecular target for anti-inflammatory and anti-cancer therapeutic strategies [3, 7].
• Enables dissection of ligand-receptor specificity using CRISPR-engineered cell models [1, 4, 8].
Structure and Composition of macrophage migration inhibitory factor receptor complex
CD74 as the ligand-binding subunit
In simple terms: CD74 is the part of the receptor that directly grabs MIF.
CD74 is a type II transmembrane protein that serves as the primary ligand-binding subunit of the MIF receptor complex. It was originally identified as the invariant chain involved in MHC class II antigen presentation, but it also functions as a cell surface receptor for MIF. CD74 expression is regulated in immune cells and can be induced in various tissues during inflammation [1, 4].
CD44 as the signal-transducing co-receptor
In simple terms: CD44 is the partner that helps CD74 send signals into the cell.
CD44 is a cell surface glycoprotein that associates with CD74 to form the MIF receptor complex. While CD74 binds MIF, CD44 is required for signal transduction, particularly for activation of downstream kinases and cytokine production [1, 4]. The CD74-CD44 complex is considered the canonical MIF receptor.
Heteromeric complexes with chemokine receptors
In simple terms: CD74 can also team up with other receptors like CXCR4 to form alternative MIF receptors.
Beyond CD44, CD74 can form functional heteromeric complexes with chemokine receptors such as CXCR4, creating alternative MIF receptor configurations. These heteromeric complexes can mediate distinct signaling outcomes and may explain tissue-specific effects of MIF. The existence of multiple receptor complexes highlights the complexity of MIF biology.
Assembly and membrane localization
In simple terms: The receptor parts come together at the cell surface to catch MIF.
The MIF receptor complex assembles at the plasma membrane, where CD74 and CD44 are co-expressed [1, 4]. Assembly is likely regulated by protein trafficking and post-translational modifications, though precise mechanisms require further study. The complex is dynamic and can be modulated by cellular activation states.
Key Genes Involved in GO:0035692 macrophage migration inhibitory factor receptor complex
The following genes encode the core and associated components of the macrophage migration inhibitory factor receptor complex and related signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD74 | Ligand-binding subunit of the MIF receptor complex; binds MIF | Central to MIF signaling; target for knockout and knock-in studies [1, 4] |
| CD44 | Signal-transducing co-receptor; associates with CD74 | Required for MIF-induced signaling; knockout models reveal functional dependence [1, 4] |
| MIF | Ligand that binds the receptor complex | Knockout and overexpression models define MIF-dependent phenotypes [3, 5] |
| CXCR4 | Chemokine receptor that can form heteromeric complexes with CD74 | Alternative MIF receptor component; relevant in cancer and inflammation |
| NLRP3 | Inflammasome activated downstream of MIF receptor signaling | Readout of MIF receptor function in inflammation |
| IL-6 | Cytokine induced by MIF signaling | Marker of MIF receptor activation |
| TNF | Cytokine modulated by MIF | Indicator of inflammatory signaling downstream of the receptor |
| AKT1 | Kinase activated downstream of MIF receptor | Survival signaling mediator |
| MAPK1 | Kinase in MIF signaling cascade | Proliferation and survival pathways |
| NFKB1 | Transcription factor activated by MIF signaling | Inflammatory gene expression |
| CD3E | T cell marker used to study MIF effects on T cells | Context for CD74 expression in COVID-19 |
| CD4 | T helper cell marker | Effector T cell expansion studies |
| CD8A | Cytotoxic T cell marker | Effector T cell differentiation studies |
| NKG2D | NK cell receptor; NKT cell populations affected by MIF | NASH fibrosis studies |
| GFAP | Astrocyte marker; neural stem/progenitor cell context | MIF effects on neural cells |
| SOX2 | Neural stem cell marker | MIF promotes neural stem/progenitor cell survival |
| VIM | Mesenchymal marker; glioblastoma context | MIF role in glioblastoma |
| CD68 | Macrophage marker | MIF biology in macrophages |
How Is macrophage migration inhibitory factor receptor complex Regulated?
The MIF receptor complex is regulated at multiple levels. CD74 expression is induced by inflammatory stimuli and is associated with effector T cell expansion in COVID-19 patients. CD44 expression and post-translational modifications can modulate complex formation and signaling. MIF itself is regulated by hypoxia and inflammatory cues, and its binding to the receptor complex initiates feedback loops involving NF-kB and NLRP3 inflammasome activation [2, 3]. Additionally, heteromeric complex formation with CXCR4 provides a regulatory node that can shift signaling specificity.
macrophage migration inhibitory factor receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD74 | COVID-19 immunopathology | CD74 knockout T cells followed by SARS-CoV-2 antigen stimulation |
| MIF | Inflammatory arthritis | MIF knockout mice with U1 snRNP immune complex challenge |
| CD74 | Glioblastoma | CD74 knockdown in glioblastoma cell lines |
| MIF | Neural stem cell survival | MIF overexpression in neural stem/progenitor cells |
| MIF | NASH fibrosis | MIF knockout mice on high-fat diet |
COVID-19 and immune dysregulation
CD74 expression, a key component of the MIF receptor complex, is associated with expansion and differentiation of effector T cells in COVID-19 patients. This suggests that the MIF receptor complex contributes to the immunopathology of severe viral infections.
Inflammatory arthritis and inflammasome activation
MIF regulates U1 small nuclear RNP immune complex-mediated activation of the NLRP3 inflammasome, a process dependent on the MIF receptor complex. This links the receptor complex to autoimmune arthritis pathogenesis.
Glioblastoma and neural cell survival
MIF promotes cell survival and proliferation of neural stem/progenitor cells and plays a role in primary glioblastoma multiforme cells [5, 6]. The MIF receptor complex is therefore implicated in brain tumor biology and neural regeneration [5, 6].
Non-alcoholic steatohepatitis (NASH)
MIF has an unexpected pro-fibrotic effect in NASH that is linked to a shift in NKT cell populations, potentially involving the MIF receptor complex. This highlights the complex role of MIF signaling in metabolic liver disease.
From macrophage migration inhibitory factor receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD74 mediate MIF-induced T cell expansion? | CD74 knockout Jurkat or primary T cells |
| Is CD44 required for MIF receptor signaling? | CD44 knockout cell lines [1, 4] |
| Can point mutations in CD74 disrupt MIF binding? | CD74 point-mutant knock-in cells |
| Does CXCR4 heteromerization alter MIF signaling? | CXCR4/CD74 double knockout or knock-in |
| What is the effect of MIF overexpression on neural stem cells? | MIF overexpression lentiviral models |
| How does MIF receptor complex activation affect inflammasome? | NLRP3 reporter macrophages with CD74 knockout |
How to Study the macrophage migration inhibitory factor receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface expression of CD74 and CD44 | Immune cell phenotyping in COVID-19 |
| Co-immunoprecipitation | Protein-protein interactions | CD74-CD44 complex detection |
| Proximity ligation assay | In situ protein proximity | CD74-CXCR4 heteromer validation |
| RNA-seq | Transcriptional changes | MIF-induced gene expression [1, 2] |
| ELISA | Cytokine secretion | IL-6 and TNF measurement |
| Western blot | Signaling pathway activation | AKT and MAPK phosphorylation |
| Inflammasome assay | NLRP3 activation | MIF-dependent inflammasome studies |
| Immunohistochemistry | Tissue expression of CD74 | Glioblastoma and NASH samples [5, 7] |
Flow cytometry and immunophenotyping
Flow cytometry is used to measure CD74 and CD44 surface expression on immune cells and to assess effector T cell expansion in patient samples. This method allows quantification of receptor complex components at single-cell resolution.
Co-immunoprecipitation and proximity ligation
Co-immunoprecipitation and proximity ligation assays can detect physical association between CD74 and CD44 or CXCR4, confirming receptor complex assembly [4, 8]. These methods are essential for validating heteromeric complex formation.
RNA-seq and transcriptomics
RNA sequencing reveals transcriptional programs downstream of MIF receptor complex activation, including cytokine and chemokine gene expression [1, 2]. This approach can identify biomarkers and pathways regulated by the complex.
Functional immune assays
Inflammasome activation assays and cytokine production measurements (e.g., IL-6, TNF) are used to assess functional consequences of MIF receptor complex engagement [2, 3]. These assays link receptor activity to inflammatory outcomes.
How CRISPR Can Be Used to Study GO:0035692 macrophage migration inhibitory factor receptor complex
Knockout
CRISPR knockout of CD74 or CD44 in immune cell lines or primary cells can abolish MIF receptor complex function, enabling researchers to test whether MIF-induced phenotypes depend on the complex [1, 4]. Knockout models are particularly useful for validating receptor specificity.
Point Mutation
Point mutations in CD74 can be introduced to disrupt MIF binding or to mimic disease-associated variants, allowing fine mapping of interaction interfaces. Such models help distinguish ligand-binding from signaling functions.
Knock-in
Knock-in of tagged CD74 or CD44 (e.g., fluorescent or epitope tags) enables real-time tracking of receptor complex assembly and trafficking [4, 8]. Tagged knock-in models are valuable for imaging and proteomic studies.
Overexpression
Overexpression of MIF or CD74 can amplify receptor complex signaling and is used to study gain-of-function effects in cancer and neural cells [5, 6]. Overexpression models complement knockout studies by revealing sufficiency.
How EDITGENE Supports macrophage migration inhibitory factor receptor complex Research
Researchers studying macrophage migration inhibitory factor receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, ligand binding, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for macrophage migration inhibitory factor receptor complex research.
Frequently Asked Questions About macrophage migration inhibitory factor receptor complex
What is the macrophage migration inhibitory factor receptor complex?
It is a cell surface protein complex defined by GO:0035692 that binds MIF and comprises CD74 and CD44 [1, 4].
What genes are involved in the macrophage migration inhibitory factor receptor complex?
The core genes are CD74 and CD44; additional components can include CXCR4 in heteromeric complexes [1, 4, 8].
What is the function of CD74 in the MIF receptor complex?
CD74 acts as the ligand-binding subunit that directly binds MIF.
How does CD44 contribute to MIF signaling?
CD44 serves as a signal-transducing co-receptor required for downstream signaling [1, 4].
Which diseases are associated with the MIF receptor complex?
It is implicated in COVID-19 immunopathology, inflammatory arthritis, glioblastoma, and NASH [1, 2, 5, 7].
How can CRISPR be used to study the MIF receptor complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of CD74 and CD44 [1, 4, 8].
What methods are used to study the MIF receptor complex?
Flow cytometry, co-immunoprecipitation, RNA-seq, and functional immune assays are commonly used [1, 2, 4, 8].
Is the MIF receptor complex a therapeutic target?
Yes, targeting MIF signaling via its receptor complex is being explored for inflammatory and fibrotic diseases [3, 7].
What is the role of MIF in neural stem cells?
MIF promotes cell survival and proliferation of neural stem/progenitor cells.
How does MIF receptor complex activate the NLRP3 inflammasome?
MIF regulates U1 snRNP immune complex-mediated activation of the NLRP3 inflammasome.
Conclusion
The macrophage migration inhibitory factor receptor complex (GO:0035692) is a critical cell surface signaling hub composed of CD74 and CD44 that mediates the diverse biological effects of MIF [1, 4]. Its involvement in immune regulation, inflammation, cancer, and metabolic disease makes it a high-priority target for basic and translational research [2, 3, 5, 7]. CRISPR-based models and integrated multi-omics approaches are essential for unraveling the complex biology of this receptor complex [1, 4, 8].
References
- 1. Westmeier J et al.. 2023. Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients.. Front Immunol 14:1236374 PMID: 37946732
- 2. Shin MS et al.. 2019. Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome.. Arthritis Rheumatol 71(1):109-120 PMID: 30009530
- 3. Lue H et al.. 2002. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.. Microbes Infect 4(4):449-60 PMID: 11932196
- 4. Schröder B. 2016. The multifaceted roles of the invariant chain CD74--More than just a chaperone.. Biochim Biophys Acta 1863(6 Pt A):1269-81 PMID: 27033518
- 5. Baron N et al.. 2011. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.. J Neurosci Res 89(5):711-7 PMID: 21360573
- 6. Ohta S et al.. 2012. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.. J Cell Sci 125(Pt 13):3210-20 PMID: 22454509
- 7. Heinrichs D et al.. 2021. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.. Cells 10(2) PMID: 33525493
- 8. Schwartz V et al.. 2009. A functional heteromeric MIF receptor formed by CD74 and CXCR4.. FEBS Lett 583(17):2749-57 PMID: 19665027
